These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8528431)

  • 1. Time preference, duration and health state valuations.
    Dolan P; Gudex C
    Health Econ; 1995; 4(4):289-99. PubMed ID: 8528431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling valuations for health states: the effect of duration.
    Dolan P
    Health Policy; 1996 Dec; 38(3):189-203. PubMed ID: 10162421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing health status using VAS and TTO: what lies behind the numbers?
    Robinson A; Dolan P; Williams A
    Soc Sci Med; 1997 Oct; 45(8):1289-97. PubMed ID: 9381241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time trade-off method: results from a general population study.
    Dolan P; Gudex C; Kind P; Williams A
    Health Econ; 1996; 5(2):141-54. PubMed ID: 8733106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuing health states: a comparison of methods.
    Dolan P; Gudex C; Kind P; Williams A
    J Health Econ; 1996 Apr; 15(2):209-31. PubMed ID: 10159110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing health state valuations for disease specific states: an example from heart disease.
    Kirsch J; McGuire A
    Health Econ; 2000 Mar; 9(2):149-58. PubMed ID: 10721016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs.
    Bleichrodt H; Johannesson M
    J Health Econ; 1997 Apr; 16(2):155-75. PubMed ID: 10169092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead time TTO: leading to better health state valuations?
    Attema AE; Versteegh MM; Oppe M; Brouwer WB; Stolk EA
    Health Econ; 2013 Apr; 22(4):376-92. PubMed ID: 22396243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparability and reliability of five health-state valuation methods.
    Krabbe PF; Essink-Bot ML; Bonsel GJ
    Soc Sci Med; 1997 Dec; 45(11):1641-52. PubMed ID: 9428084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated current health time-trade-off assessments in women's health.
    Tosteson AN; Kneeland TS; Nease RF; Sumner W
    Value Health; 2002; 5(2):98-105. PubMed ID: 11918825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.
    Arnesen T; Trommald M
    Health Econ; 2005 Jan; 14(1):39-53. PubMed ID: 15386674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregating health state valuations.
    Dolan P
    J Health Serv Res Policy; 1997 Jul; 2(3):160-5; discussion 166-7. PubMed ID: 10180377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What utility scores do mental health service users, healthcare professionals and members of the general public attribute to different health states? A co-produced mixed methods online survey.
    Flood C; Barlow S; Simpson A; Burls A; Price A; Cartwright M; Brini S;
    PLoS One; 2018; 13(10):e0205223. PubMed ID: 30352071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
    Dolan P; Stalmeier P
    J Health Econ; 2003 May; 22(3):445-58. PubMed ID: 12683961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.